NEW HAMPTON, N.Y., Nov. 30, 2012 (GLOBE NEWSWIRE) -- Balchem Corporation (BCPC) today announced that its Board of Directors has declared a dividend on its shares of common stock equal to $0.22 per share, payable on December 21, 2012 to holders of record on December 14, 2012. This dividend reflects a 22% increase over the prior year cash dividend.
Dino A. Rossi, Balchem's Chairman, President and CEO, stated, "This annual dividend is in recognition of a year of strong financial performance and the company's commitment to share near-term successes with our shareholders. It also reflects a view to anticipated capital requirements for other strategic growth objectives, as we remain positioned to maximize future returns for our shareholders."
Segment Information
Balchem Corporation consists of three business segments: ARC Specialty Products; Food, Pharma & Nutrition; and Animal Nutrition & Health. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The Food, Pharma & Nutrition segment provides proprietary microencapsulation solutions to a variety of applications in the human food, pharmaceutical and nutrition marketplaces. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets and certain derivative products into industrial applications.
Forward-Looking Statements
This release contains forward-looking statements, which reflect Balchem's expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Balchem's expectations, including risks and factors identified in Balchem's annual report on Form 10-K for the year ended December 31, 2011. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date.
CONTACT: Frank Fitzpatrick, Chief Financial Officer
Telephone: 845-326-5600
Source: Balchem Corporation
2012 GlobeNewswire, Inc.
FORGET THE DIVIDENDS AND FOCUS ON THIS BEING WHAT IT HAS BEEN, NAMELY THE BEST PERFORMING (COMPOUNDER OF SHARE PRICE) OF ANY U S STOCK OVER THE PAST 25 YEARS BARRING NONE. (1)
GOING FORWARD IT HAS SO MUCH GOING FOR IT INCLUDING:
1-INVESTMENT OF GROWING CASH HOARD, SOON TO APPROXIMATE $200 MILLION, IN A BUSINESS OR BUSINESSES RELATED TO PRESENT OPERATIONS WHICH WILL RETURN NEAR 20% ROE AS HAVE ALL AQUISITIONS DONE TO DATE. CEO, DINO ROSSI, IS "NOT GOING TO SWING "UNLESS AND UNTIL HE FINDS A "FAT PITCH" VALUE THAT FITS.
2-CureMark ALONE OFFERS A POTENTIAL TO BRING IN AS MUCH PROFIT AS THE COMPANY HAD IN ALL OF 2010
3- CONTINUED GROWTH OF EXISTING BUSINESS
PATIENCE HAS BROUGHT GREAT PROFITS FROM INVESTMENT IN BALCHEM AND AND IF CONTINUED PAST CAN PROVE PROLOGUE (1)
"I am not an adventurer by choice but by fate." --Vincent van Gogh
_________________
(1) Source http://www.smplp.com Letters to partners September 30, 2012
The best compounding companies in the United States since January 1, 1986 through September 24, 2012.
Source: FactSet
Balchem Rank is #1
CAGR is +27.4%
Stock Price at Starting Date was $0.66
Stock Price at Ending date was $37.5
Note: HD was 5th on list at +23.6%, AAPL was in 6th place at +23.5%